Home / 2017 (page 107)

Yearly Archives: 2017

Jan. 12, 2017

We have had many articles that look at why certain people develop insulin resistance more easily than others. There are many different theories as to why this resistance occurs, but in every case no one has offered a real solution to this problem. In our second special report on the …

Read More »

A New Paradigm in the Understanding and Treatment of the Metabolic Syndrome, Part 2

As concluded in the previous newsletter in this series, “Evolutionary selection for insulin resistance in a cyclic environment: brain clocks and control of peripheral metabolism” the brain is equipped with circadian neurophysiological mechanisms to induce (and reverse) the insulin resistant state that evolved as a survival strategy against ensuing environmental stresses such as prolonged (seasonal) lack of food availability. A central facilitator of this insulin resistance induction is a diminution of the circadian peak in dopaminergic activity at the SCN. Neurotoxin induced destruction of these dopaminergic projections to the clock of insulin sensitive animals induces marked insulin resistance and glucose intolerance without alterations in food consumption.

Read More »

Jan. 10, 2017

Five or six years ago, the widespread advertising of $4 dollar drug programs was in the wheelhouse of every pharmacy, and there were hundreds of drugs on the list. Since then the list has gotten much shorter and the number of pharmacies advertising them has decreased. Part of the reason …

Read More »

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #57: Mechanisms of Insulin Signal Transduction Part 1 of 8

Fuel homeostasis: The peptide hormone insulin is secreted from pancreatic beta cells, and exerts a broad spectrum of anabolic effects in multiple tissues. In response to a meal, insulin stimulates uptake and storage of carbohydrate, fat, and amino acids, while, at the same time, antagonizing the catabolism of these fuel reserves.

Read More »

Jan. 7, 2017

The ADA has announced their new Standards of Care for 2017 and they are taking a more global approach to A1C, CVD and hypoglycemia. When it comes to CVD, there is a bigger push to get patients to improve blood pressure levels. They recommend more widespread use of ARB’s and …

Read More »